Dr Anne Peters discusses updates in the ADA 2026 Standards of Care in Diabetes, focusing on the use of technology.

Afrezza is a rapid-acting inhaled human insulin indicated to improve glycemic control in adults with diabetes mellitus.

Pelayo was introduced to inhaled insulin by her endocrinologist, Dr. Nora Barsony. “It's a little tiny powder that goes right ...

For more than a century, oral insulin has been considered a "dream" therapy for diabetes, hindered by enzymatic degradation ...

Updated initial conversion table based on clinical trials in adults showing significantly improved mealtime glycemic ...

Type 2 diabetes, linked to insulin resistance, affects a significant portion of the American population, many undiagnosed. Pre-diabetes, also caused by insulin resistance, often progresses to Type 2 ...

Carbohydrate counting significantly lowers HbA1c levels in children and adolescents with Type 1 diabetes, offering a flexible dietary approach. The method remains underutilized due to complexity, ...

The City of Providence, along other municipalities and states, is taking big pharma to court over the price of insulin.

Modern technology remains a privilege, not a right, as families of people with diabetes struggle to afford rising ...